Clear cell sarcoma kidney: clinical features and outcome.

Area of Science:

• Pediatric Oncology
• Medical Research
• Cancer Treatment

Background:

• Clear cell sarcoma of kidney (CCSK) is a rare and highly malignant pediatric tumor.
• Understanding clinical features and treatment outcomes is crucial for improving patient survival.

Purpose of the Study:

• To report the clinical features and treatment outcomes of 12 pediatric patients diagnosed with CCSK.
• To evaluate the efficacy of combined modality treatment in CCSK patients.

Main Methods:

• Retrospective analysis of 12 CCSK cases diagnosed between 1982 and 1996.
• Staging according to the National Wilms' Tumor Study (NWTS) III criteria.
• Treatment involved chemotherapy (vincristine, actinomycin, Adriamycin) and radiotherapy.
• Survival analysis using the Kaplan-Meier method.

Main Results:

• Abdominal mass and pain were the primary presenting symptoms.
• The male to female ratio was 3:1.
• Six patients had Stage I, 4 had Stage II, and 2 had Stage III disease.
• Overall survival and disease-free survival rates for 10 evaluable patients were 64% and 56%, respectively.
• Six patients achieved long-term disease-free survival (10-108 months).

Conclusions:

• Combined modality treatment, including chemotherapy and radiotherapy, appears to cure approximately two-thirds of children with CCSK.
• There is a need to develop more effective treatments for pediatric patients who do not respond to initial therapy or experience recurrence.